The primary purpose of this study is to explore the feasibility of conducting a clinical trial on the effects of psilocybin for individuals with prolonged grief disorder (PGD)....
NCT ID: NCT06724289 Phase: EARLY_PHASE1 Enrollment Target: 12 Status: Recruiting
The primary purpose of this study is to explore the feasibility of conducting a clinical trial on the effects of psilocybin for individuals with prolonged grief disorder (PGD).
[Draft — editorial context needed]
Dave Asprey's annual biohacking conference featuring cutting-edge health optimization, longevity science, and performance technology demonstrations.
A major biohacking expo focused on wellness, longevity, and biohacking technologies, bringing together practitioners and innovators.
Stay Regulated
New research, honest product reviews, neurotech funding rounds, and events — delivered weekly, with zero sponsors or ads.